Sa1914 - Proactive Monitoring of Infliximab (IFX) and Adalimumab (ADA) Drug and Anti-Drug Antibody Concentration Utilizing the Labcorp Assay in Inflammatory Bowel Disease (IBD) Patients
| Autor: | Perinbasekar, Rajiv A., Brown, Sara A., Syed, Nauroz, Lonsako, Shumet, Cross, Raymond K. |
|---|---|
| Zdroj: | In Gastroenterology April 2017 152(5) Supplement 1:S392-S392 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|